Are you Dr. Dodd?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Dylan Dodd, MD is a board certified pathologist in Stanford, California. He is currently licensed to practice medicine in California. He is affiliated with Lucile Packard Children's Hospital Stanford.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2014 - 2017
- University of Illinois College of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2014 - 2025
- American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- 4 citationsClinical utility of an ultrasensitive urinary free cortisol assay by tandem mass spectrometry.Amy Luo, El Taher M. El Gierari, Laura M. Nally, Lillian R. Sturmer, Dylan Dodd
Steroids. 2019-04-02 - 736 citationsA gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolitesDylan Dodd, Matthew H. Spitzer, Will Van Treuren, Bryan D. Merrill, Andrew J. Hryckowian
Nature. 2017-11-22 - 38 citationsgutSMASH predicts specialized primary metabolic pathways from the human gut microbiota.Victòria Pascal Andreu, Hannah E Augustijn, Lianmin Chen, Alexandra Zhernakova, Jingyuan Fu
Nature Biotechnology. 2023-10-01
Press Mentions
- Microbial Metabolism of L-tyrosine Protects Against Allergic Airway InflammationJanuary 25th, 2021
- Venrock Takes the Wrap off Its First Microbiome Startup, Armed with $50M, a CEO from 23andMe and Two Founders from StanfordOctober 7th, 2020
- Getting to the Gut: $50 Million Round Backs Microbiome Startup Led by 23andMe ExecOctober 7th, 2020
- Join now to see all